S7 is a short synthetic peptide designed with balanced polar and hydrophobic residues to support structural adaptability. Its compact sequence allows exploration of binding motifs and conformational transitions in model systems. Researchers analyze its folding behavior through spectroscopic and computational approaches. Applications include motif screening, ligand-design development, and structure-activity studies.
CAT No: R2813
Synonyms/Alias:L-Leucine;L-leucyl-L-seryl-L-leucyl-L-isoleucyl-L-threonyl-L-arginyl;853248-13-2;S7 (trifluoroacetate salt);DTXSID40462527;(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoic acid
S7, also known as a selective serotonin receptor agonist, is a synthetic small molecule compound frequently utilized in neurochemical and pharmacological research. Structurally designed to modulate specific serotonin receptor subtypes, S7 demonstrates high affinity and selectivity within the central nervous system's serotonergic pathways. Its unique receptor targeting profile makes it a valuable tool for elucidating the functional roles of serotonin in neurobiology, synaptic signaling, and behavioral modulation. Researchers rely on compounds like S7 to investigate the molecular mechanisms underlying neurotransmitter action and to develop a deeper understanding of serotonergic regulation in both physiological and pathological states.
Receptor Pharmacology: In receptor pharmacology studies, S7 serves as a precise probe for characterizing serotonin receptor subtype function and distribution. By selectively activating particular serotonin receptors, it enables detailed mapping of downstream signaling cascades and receptor-mediated cellular responses. This targeted approach is essential for differentiating between the effects of various receptor subtypes and for dissecting the complexities of serotonergic neurotransmission at the molecular and cellular levels.
Neurotransmitter Pathway Analysis: The compound is widely employed in investigations of serotonergic signaling pathways within neuronal networks. Through controlled application in in vitro or ex vivo systems, S7 assists in delineating the contributions of serotonin receptors to synaptic transmission, neuronal excitability, and plasticity. Such studies are critical for advancing the understanding of neurotransmitter dynamics and for identifying key modulatory nodes within neural circuits.
Behavioral Neuroscience Research: S7 is instrumental in behavioral neuroscience experiments designed to assess the impact of selective serotonin receptor activation on animal models. Its use allows researchers to correlate specific receptor engagement with alterations in mood, cognition, anxiety, or other behavioral phenotypes. These insights are foundational for constructing mechanistic models of behavior and for identifying potential molecular targets for further research.
Drug Discovery and Screening: In early-stage drug discovery, S7 provides a benchmark for evaluating the activity and selectivity of novel serotonin receptor ligands. Its well-characterized pharmacological profile makes it an ideal reference compound in high-throughput screening assays, binding studies, and functional assessments. This application supports the identification and optimization of candidate molecules with desirable serotonergic properties for further preclinical development.
Signal Transduction Studies: The compound is also employed to investigate intracellular signaling events triggered by serotonin receptor activation. By stimulating defined receptor populations, S7 enables the analysis of second messenger systems, kinase activation, and gene expression changes downstream of serotonergic input. These studies are invaluable for unraveling the molecular basis of receptor-mediated effects and for exploring the broader implications of serotonin signaling in cellular physiology.
2. TMEM16F and dynamins control expansive plasma membrane reservoirs
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More